Mark Murcko - Sep 8, 2022 Form 4 Insider Report for Relay Therapeutics, Inc. (RLAY)

Role
Director
Signature
/s/ Brian Adams, as attorney-in-fact
Stock symbol
RLAY
Transactions as of
Sep 8, 2022
Transactions value $
-$748,750
Form type
4
Date filed
9/8/2022, 08:31 PM
Previous filing
May 27, 2022
Next filing
Jun 1, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RLAY Common Stock Sale -$749K -25K -2.45% $29.95 997K Sep 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 12, 2022.